文献速递呼吸危重症与机械通气

美国急性呼吸衰竭支气管镜使用的时间趋势与变异

Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United States.
PubMed 文献 · Chest · 2022-08-22

BACKGROUND: National data on bronchoscopy for the evaluation of acute respiratory failure are lacking, and the limited available data suggest wide variation in use.…

要点

  • 有创机械通气患者中支气管镜使用比例从2012年9.5%升至2018年10.8%。
  • 2018年1787家医院中支气管镜使用率从0%到57.1%不等。
  • 调整患者和医院特征后,16.0%的变异归因于医院层面,中位OR为2.13。

核心结论

  • 有创机械通气住院患者中支气管镜使用随时间增加,但医院间存在大幅差异,提示潜在不必要实践变异。

研究设计与样本

  • 观察性队列研究,使用美国全国住院样本(覆盖97%住院)分析2012-2018年成人有创机械通气住院患者。

主要发现

  • 共识别6,101,070例有创机械通气住院,其中609,405例接受支气管镜;接受支气管镜者平均年龄61岁,女性占41.8%,院内死亡率为30.8%。
  • 2018年1787家医院中支气管镜使用率范围为0%至57.1%,多水平模型调整后16.0%的变异由医院层面解释,中位OR为2.13(95%CI 2.05-2.21)。

临床怎么用

  • 临床医生应意识到支气管镜在急性呼吸衰竭患者中的使用存在显著医院间差异,需结合患者个体情况审慎决策。

局限性

  • 研究为观察性设计,无法确定支气管镜使用的适应证及是否恰当,也无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: National data on bronchoscopy for the evaluation of acute respiratory failure are lacking, and the limited available data suggest wide variation in use. RESEARCH QUESTION: How commonly is bronchoscopy performed among hospitalizations with acute respiratory failure? How has use changed over time and across hospitals? STUDY DESIGN AND METHODS: This was an observational cohort study of adult hospitalizations (2012-2018) treated with invasive mechanical ventilation (IMV) using the National Inpatient Sample, which represents 97% of all hospitalizations in the United States. We measured the proportion of hospitalizations treated with IMV who underwent bronchoscopy and assessed trends in bronchoscopy use over time. Multilevel linear regression models were used to quantify hospital-level variation, adjusting for differences in patient and hospital characteristics. RESULTS: We identified 6,101,070 IMV-treated hospitalizations (2012-2018), of whom 609,405 underwent bronchoscopy; among hospitalizations receiving bronchoscopy, mean age was 61 years, 41.8% were women, and in-hospital mortality was 30.8%. The percentage of IMV-treated hospitalizations receiving bronchoscopy increased from 9.5% (95% CI, 9.1%-9.9%) in 2012 to 10.8% (95% CI, 10.4%-11.2%) in 2018 (P < .001 for difference). In 2018, bronchoscopy use varied from 0% to 57.1% among 1,787 hospitals, and in multilevel models adjusted for patient and hospital characteristics, 16.0% of the variation was explained at the hospital level. The median OR was 2.13 (95% CI, 2.05-2.21), indicating 113% increased odds of receiving bronchoscopy if moving from a lower-use to a higher-use hospital. INTERPRETATION: Bronchoscopy use among hospitalizations treated with IMV has increased over time. The large variation in use of bronchoscopy across hospitals suggests potentially unwarranted practice variation and need for further studies to clarify which patients benefit from bronchoscopy.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Wayne MT, Valley TS, Arenberg DA, et al. Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United States. Chest. 2022. PMID: 36007595. doi:10.1016/j.chest.2022.08.2210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。